Tizanidine Tablet
Product Images NDC 68788-7991

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 68788-7991). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine Hydrochloride Tablet 2mg (Container1)

This is a description of a medication called Tizanidine Hydrochloride Tablet 2mg, which is a generic version of the drug Zanaflex. The drug contains 2.288 mg tizanidine hydrochloride USP and is manufactured by Dr Reddy's Laboratories Limited. The label warns that federal law prohibits transferring the drug to anyone other than the patient it was prescribed to. The packaging includes information such as the lot number and expiration date.*

FDA Label Image

Fig1 (Fig1)

This text provides a table showing the plasma Tzanidine Concentration (ng/mL) at different time points after taking different dosages (2x 4mg Tzanidine Tablets or Capsules) with or without food. There is no further information available.*

FDA Label Image

Fig2 (Fig2)

FDA Label Image

Fig3 (Fig3)

This appears to be a table or chart displaying information related to a study on the improvement in Ashworth Score for zanidine at a mean dose of 28.6 mg over a period of 7 weeks, with the endpoint being the end of the maintenance period. However, the table or chart is incomplete and lacks further context or details.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.